Daniel R Chard Medifast Inc (MED) insider trading activity

Daniel R Chard is Chairman & CEO of MEDIFAST INC. Currently has a direct ownership of 51,293 shares of MED, which is worth approximately $746,313. The most recent transaction as insider was on Mar 17, 2025, when has been sold 1,864 shares (Common Stock) at a price of $14.35 per share, resulting in proceeds of $26,748. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 51.3K

48.62% 3M change

48.62% 12M change

Total Value Held $746,313

Daniel R Chard Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 17 2025	SELL Payment of exercise price or tax liability	$26,748 $14.35 p/Share	1,864 Reduced 3.51%	51,293 Common Stock
Mar 16 2025	SELL Payment of exercise price or tax liability	$13,159 $13.94 p/Share	944 Reduced 1.74%	53,157 Common Stock
Mar 13 2025	SELL Payment of exercise price or tax liability	$69,363 $13.87 p/Share	5,001 Reduced 8.46%	54,101 Common Stock
Mar 15 2024	SELL Payment of exercise price or tax liability	$124,803 $36.61 p/Share	3,409 Reduced 3.3%	99,821 Common Stock
Mar 13 2024	BUY Grant, award, or other acquisition	-	45,087 Added 30.4%	103,230 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$288,212 $52.68 p/Share	5,471 Reduced 8.6%	58,143 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	16,486 Added 20.58%	63,614 Common Stock
Mar 17 2023	SELL Payment of exercise price or tax liability	$89,598 $102.75 p/Share	872 Reduced 2.8%	30,321 Common Stock
Mar 17 2023	BUY Grant, award, or other acquisition	-	16,807 Added 26.29%	47,128 Common Stock
Mar 16 2023	SELL Payment of exercise price or tax liability	$141,856 $104.46 p/Share	1,358 Reduced 4.17%	31,193 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$1,720,573 $109.99 p/Share	15,643 Reduced 32.46%	32,551 Common Stock
Feb 24 2023	BUY Grant, award, or other acquisition	-	34,076 Added 41.42%	48,194 Common Stock
Feb 21 2023	SELL Payment of exercise price or tax liability	$209,287 $115.31 p/Share	1,815 Reduced 11.39%	14,118 Common Stock
Mar 21 2022	SELL Bona fide gift	-	953 Reduced 5.64%	15,933 Common Stock
Mar 17 2022	SELL Payment of exercise price or tax liability	$158,497 $180.52 p/Share	878 Reduced 4.15%	20,261 Common Stock
Mar 16 2022	BUY Grant, award, or other acquisition	-	8,509 Added 28.7%	21,139 Common Stock
Feb 23 2022	SELL Bona fide gift	-	3,375 Reduced 16.66%	16,886 Common Stock
Feb 22 2022	SELL Payment of exercise price or tax liability	$546,407 $177.06 p/Share	3,086 Reduced 19.64%	12,630 Common Stock
Jan 03 2022	SELL Bona fide gift	-	12,539 Reduced 44.38%	15,716 Common Stock
Dec 31 2021	SELL Payment of exercise price or tax liability	$2,415,356 $209.43 p/Share	11,533 Reduced 28.99%	28,255 Common Stock
Dec 31 2021	BUY Exercise of conversion of derivative security	-	24,072 Added 37.69%	39,788 Common Stock
Nov 04 2021	SELL Bona fide gift	-	90,610 Reduced 85.22%	15,716 Common Stock
Jun 17 2021	SELL Open market or private sale	$1,684,306 $264.62 p/Share	6,365 Reduced 5.65%	106,326 Common Stock
Jun 16 2021	SELL Open market or private sale	$1,599,853 $274.7 p/Share	5,824 Reduced 4.91%	112,691 Common Stock
Jun 15 2021	SELL Open market or private sale	$2,150,262 $279.4 p/Share	7,696 Reduced 6.1%	118,515 Common Stock

DRC

Daniel R Chard

Chairman & CEO

Baltimore, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MED shares.

Notify only if

Value

Insider Trading

Get notified when an Medifast Inc insider buys or sells MED shares.

Notify only if

Operation

Value

Type

News

Receive news related to MEDIFAST INC

Track Activities on MED

Account